Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis Cohort.

Saved in:
Bibliographic Details
Title: Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis Cohort.
Authors: Einsiedler M; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Zecca C; Multiple Sclerosis Center, Neurocenter of Southern Switzerland, EOC, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Hofer L; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Benkert P; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Axfors C; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Bedussi F; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Lugano, Switzerland., Ceschi A; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Lugano, Switzerland., Disanto G; Multiple Sclerosis Center, Neurocenter of Southern Switzerland, EOC, Lugano, Switzerland., Müller J; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Oechtering J; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Lorscheider J; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Galli E; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Fischer-Barnicol B; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., D'Souza M; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Schaedelin SA; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Maleska Maceski A; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Hoepner R; Department of Neurology, Inselspital Bern, University Hospital and University of Bern, Switzerland., Chan A; Department of Neurology, Inselspital Bern, University Hospital and University of Bern, Switzerland., Granziera C; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Finkener S; Department of Neurology, Cantonal Hospital Aarau, Switzerland., Achtnichts L; Department of Neurology, Cantonal Hospital Aarau, Switzerland., Pot C; Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Switzerland., Du Pasquier RA; Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Switzerland., Uginet M; Department of Neurology, University Hospital of Geneva, Switzerland., Lalive PH; Department of Neurology, University Hospital of Geneva, Switzerland., Mueller S; Department of Neurology, Cantonal Hospital St. Gallen, Switzerland; and., Roth P; Department of Neurology, University Hospital Zurich and University of Zurich, Switzerland., Kappos L; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Gobbi C; Multiple Sclerosis Center, Neurocenter of Southern Switzerland, EOC, Lugano, Switzerland., Derfuss TJ; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Leppert D; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Kuhle J; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Yaldizli Ö; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland.
Corporate Authors: as the Swiss Multiple Sclerosis Cohort Study
Source: Neurology. Clinical practice [Neurol Clin Pract] 2025 Aug; Vol. 15 (4), pp. e200499. Date of Electronic Publication: 2025 Jul 02.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101577149 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2163-0402 (Print) Linking ISSN: 21630402 NLM ISO Abbreviation: Neurol Clin Pract Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2163-0402
DOI:10.1212/CPJ.0000000000200499